Literature DB >> 34903064

Alteration of autophagy-related protein 5 (ATG5) levels and Atg5 gene expression in diabetes mellitus with and without complications.

Remah Yassin1, Hagar Tadmor1,2, Evgeny Farber1,3, Anas Igbariye1, Aida Armaly-Nakhoul1, Inbal Dahan1, Farid Nakhoul1,2, Nakhoul Nakhoul2,3.   

Abstract

BACKGROUND: Autophagy is a catabolic mechanism that involves lysosomal-dependent degradation of unnecessary intracellular components and responsible for normal cellular homeostasis. Autophagy pathway and its key participant ATG5/LC3 are associated with several pathologies such as diabetes mellitus and its complications.
METHODS: Levels and expression of autophagy key components ATG5 and LC3B were analyzed in both human model and murine tissues. One hundred and twenty human subjects were divided into four groups: Healthy (control), diabetes mellitus without complications, diabetic nephropathy, and diabetic retinopathy. Additionally, we used kidneys from WT healthy and diabetic nephropathy mice. Lysate derived from human peripheral blood mononuclear cells and murine renal cortex lysates were subjected to western blot and immunohistochemical analysis.
RESULTS: Western blot and immunohistochemical analysis demonstrate that ATG5 protein levels were significantly decreased in diabetes mellitus, diabetic nephropathy (DN), and diabetic retinopathy patients versus healthy controls and in DN mice compared to healthy mice (0.65 ± 0.04; 1.15 ± 0.13 A.U. units, respectively). Quantification of staining area (%) of ATG5 mice tissue expression also decreased in DN versus healthy mice (4.42 ± 1.08%; 10.87 ± 1.01%, respectively). LC3B LEVELS AND EXPRESSION: Significant reduction in peripheral blood mononuclear cells in diabetic patients (with or without complications) vs. healthy controls. Renal LC3B levels were lower in DN versus healthy mice (0.36 ± 0.03; 0.68 ± 0.07 A.U. units). Renal LC3B staining quantification revealed significant reduction in DN versus healthy mice (1.7 ± 0.23%; 8.56 ± 1.7%).
CONCLUSION: We conclude that ATG5, as well as LC3B, are down regulated in diabetic patients with or without complications. This diminution contributes to deficiencies in the autophagy process.

Entities:  

Keywords:  Atg5 gene; Diabetes Mellitus; Key Indexing Terms: Diabetic Nephropathy, Retinopathy, Autophagy, Atg5, and LC3B; LC3B; autophagy; diabetic nephropathy

Mesh:

Substances:

Year:  2021        PMID: 34903064      PMCID: PMC8679033          DOI: 10.1177/14791641211062050

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  34 in total

Review 1.  The RAAS in the pathogenesis and treatment of diabetic nephropathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

Review 2.  Autophagy and the kidney: health and disease.

Authors:  Yoshitsugu Takabatake; Tomonori Kimura; Atsushi Takahashi; Yoshitaka Isaka
Journal:  Nephrol Dial Transplant       Date:  2014-02-10       Impact factor: 5.992

Review 3.  Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.

Authors:  Nikhil Shri Sahajpal; Rajesh Kumar Goel; Alka Chaubey; Rohan Aurora; Subheet Kumar Jain
Journal:  Curr Protein Pept Sci       Date:  2019       Impact factor: 3.272

Review 4.  Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy.

Authors:  Munehiro Kitada; Yoshio Ogura; Itaru Monno; Daisuke Koya
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

Review 5.  Diabetic retinopathy.

Authors:  Ning Cheung; Paul Mitchell; Tien Yin Wong
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

6.  Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.

Authors:  Zhonghua Qi; Hiroki Fujita; Jianping Jin; Linda S Davis; Yihan Wang; Agnes B Fogo; Matthew D Breyer
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

Review 7.  Clinical and pathological factors associated with progression of diabetic nephropathy.

Authors:  Shuang Liang; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Nephrology (Carlton)       Date:  2017-12       Impact factor: 2.506

Review 8.  Diabetic nephropathy - complications and treatment.

Authors:  Andy Kh Lim
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-15

Review 9.  Molecular mechanisms and physiological roles of Atg5/Atg7-independent alternative autophagy.

Authors:  Satoko Arakawa; Shinya Honda; Hirofumi Yamaguchi; Shigeomi Shimizu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

10.  Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia-induced podocyte injury.

Authors:  Li Fang; Yang Zhou; Hongdi Cao; Ping Wen; Lei Jiang; Weichun He; Chunsun Dai; Junwei Yang
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

View more
  2 in total

Review 1.  The Mighty Mitochondria Are Unifying Organelles and Metabolic Hubs in Multiple Organs of Obesity, Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes: An Observational Ultrastructure Study.

Authors:  Melvin R Hayden
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 2.  Research progress on the relationship between autophagy and chronic complications of diabetes.

Authors:  Xia Ge; Ling Wang; Aihua Fei; Shandong Ye; Qingping Zhang
Journal:  Front Physiol       Date:  2022-08-08       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.